Índices antropométricos no rastreio da doença hepática esteatótica associada à disfunção metabólica: uma revisão da literatura
DOI:
https://doi.org/10.34119/bjhrv8n2-398Keywords:
Doença Hepática Esteatótica Associada à Disfunção Metabólica, esteatose, antropometria, obesidadeAbstract
Introdução: A Doença Hepática Esteatótica Associada à Disfunção Metabólica (MASLD) é uma condição crônica caracterizada pelo acúmulo de gordura no fígado, sendo fortemente associada à obesidade e síndrome metabólica. Objetivos: Analisar a relação entre índices antropométricos e a presença de MASLD, avaliando sua viabilidade como ferramentas acessíveis para rastreamento. Metodologia: Trata-se de uma revisão sistemática da literatura conforme as diretrizes PRISMA, pesquisando estudos de coorte nos bancos de dados PubMed, SciELO e LILACS entre 2019 e 2024 com os seguintes descritores: ("anthropometric profile" OR "body measurements" OR "waist circumference") AND ("hepatic steatosis" OR "NAFLD" OR "MASLD"). Após aplicação dos critérios de inclusão e exclusão, 16 estudos foram incluídos. Resultados: O IMC maior que 25 foi significativamente associado à MASLD. A Circunferência da Cintura (CC) também se mostrou um preditor eficaz, com AUCs variando de 0,8102 a 0,8695. Alterações na CC ao longo do tempo foram associadas a um aumento de até 196% na probabilidade de MASLD. A Circunferência do Pescoço (CP) apresentou risco elevado para MASLD, mesmo após ajustes para IMC e CC. Conclusão: IMC, CC e CP se destacam como ferramentas valiosas para rastreamento e manejo da doença.
References
AJABNOOR, G. M. A. et al. Exploring the validity of available markers and indices in the diagnosis of nonalcoholic fatty liver disease (NAFLD) in people with type 2 diabetes in Saudi Arabia. Diseases (Basel, Switzerland), v. 11, n. 1, p. 10, 2023.
Disponível em: https://doi.org/10.3390/diseases11010010. Acesso em: 19 fev. 2025.
ATSAWARUNGRUANGKIT, A.; LAOVEERAVAT, P.; PROMRAT, K. Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database. World Journal of Hepatology, v. 13, n. 10, p. 1417, 2021.
BORGES-CANHA, M. et al. Waist-to-hip ratio and inflammatory parameters are associated with risk of non-alcoholic fatty liver disease in patients with morbid obesity. Biomedicines, v. 10, n. 10, p. 2416, 2022.
CAO, W. et al. Neck circumference predicts the occurrence and remission of metabolic-associated fatty liver disease: a longitudinal study of community-dwelling population. Annals of Nutrition and Metabolism, v. 78, n. 5, p. 273-280, 2022.
CLAYPOOL, K.; LONG, M. T.; PATEL, C. J. Waist circumference and insulin resistance are the most predictive metabolic factors for steatosis and fibrosis. Clinical Gastroenterology and Hepatology, v. 21, n. 7, p. 1950-1954, 2023.
CUCORANU, D. C. et al. Correlation between CT abdominal anthropometric measurements and liver density in individuals with non-alcoholic fatty liver disease. Medicina, v. 59, n. 3, p. 500, 2023.
DENG, J. et al. Development and validation of a machine learning-based framework for assessing metabolic-associated fatty liver disease risk. BMC Public Health, v. 24, n. 1, p. 2545, 2024.
HAO, X. et al. Waistline to thigh circumference ratio as a predictor of MAFLD: a health care worker study with 2-year follow-up. BMC Gastroenterology, v. 24, n. 1, p. 144, 2024.
KORPIMÄKI, S. et al. Nonalcoholic fatty liver disease incidence and remission and their predictors during 7 years of follow-up among Finns. The Journal of Clinical Endocrinology & Metabolism, v. 109, n. 1, p. e291-e305, 2024.
LEE, J. H. et al. Association between waist circumference trajectories and incident non-alcoholic fatty liver disease. Obesity Research & Clinical Practice, v. 17, n. 5, p. 398-404, 2023.
LEE, J. H. et al. Cutoff points of waist circumference for predicting incident non-alcoholic fatty liver disease in middle-aged and older Korean adults. Nutrients, v. 14, n. 14, p. 2994, 2022.
LEE, J. H. et al. Gender differences in the risk for incident non-alcoholic fatty liver disease according to the transition of abdominal obesity status: A 16-year cohort study. Nutrients, v. 15, n. 13, p. 2880, 2023.
LIANG, Y. et al. A greater ratio of thigh subcutaneous fat to abdominal fat is associated with protection against non-alcoholic fatty liver disease. JHEP Reports, v. 5, n. 7, p. 100730, 2023.
MASAEBI, F. et al. Machine-learning application for predicting metabolic dysfunction-associated steatotic liver disease using laboratory and body composition indicators. Archives of Iranian Medicine, v. 27, n. 10, p. 551, 2024.
NAKHOSTIN-ANSARI, A. et al. Prevalence and correlates of probable nonalcoholic steatohepatitis (NASH) in Pars Cohort Study. Archives of Iranian Medicine, v. 27, n. 11, p. 598, 2024.
OTSUBO, N. et al. Utility of indices obtained during medical checkups for predicting fatty liver disease in non-obese people. Internal Medicine, v. 62, n. 16, p. 2307-2319, 2023.
PRECIADO-PUGA, M. C. et al. Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures. Annals of Hepatology, v. 21, p. 100264, 2021. Disponível em: https://doi.org/10.1016/j.aohep.2020.09.008.
PAGE, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, v. 372, n. 71, 2021. DOI: 10.1136/bmj.n71.
SEZGIN, O. et al. The abdominal ultrasonography results of Cappadocia Cohort Study of Turkey reveals high prevalence of fatty liver. The Turkish Journal of Gastroenterology: the official journal of Turkish Society of Gastroenterology, v. 34, n. 6, p. 652–664, 2023. Disponível em: https://doi.org/10.5152/tjg.2023.23067. Acesso em: 19 fev. 2025.
SHENG, G. et al. The usefulness of obesity and lipid-related indices to predict the presence of non-alcoholic fatty liver disease. Lipids in Health and Disease, v. 20, p. 1-14, 2021.
TAHIR, F. et al. Anthropometric measurements and lifestyle characteristics of individuals with non-alcoholic fatty liver disease. Cureus, v. 12, n. 2, p. e7016, 2020. Disponível em: https://doi.org/10.7759/cureus.7016. Acesso em: 19 fev. 2025.
WIAFE, Y. A. et al. Non-alcoholic fatty liver disease and liver fibrosis in persons with type 2 diabetes mellitus in Ghana: a study of prevalence, severity, and contributing factors using transient elastography. Journal of Clinical Medicine, v. 12, n. 11, p. 3741, 2023. Disponível em: https://doi.org/10.3390/jcm12113741. Acesso em: 19 fev. 2025.
YARI, Z.; FOTROS, D.; HEKMATDOOST, A. Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease. Scientific Reports, v. 13, n. 1, p. 14531, 2023.
Weijie Cao, Yiting Xu, Yun Shen, Yufei Wang, Xiaojing Ma, Yuqian Bao; Neck Circumference Predicts the Occurrence and Remission of Metabolic Associated Fatty Liver Disease: A Longitudinal Study of Community-Dwelling Population. Ann Nutr Metab 3 November 2022; 78 (5): 273–280. https://doi.org/10.1159/000526075
